Stent-graft treatment for aortic aneurysms near the abdominal organ arteries
Tests a branched stent-graft for thoracoabdominal and paravisceral aortic aneurysms in adults.
Key facts
- Who runs it
- Warren J. Gasper, MD
- Where
- San Francisco, United StatesSee the 2 sites
- Trial code
- Registry title
- Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- May 2005
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- Endovascular Branched Stent-Graft
- Record updated
- 10 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a large aneurysm (bulge) of the aorta in the chest and belly area, or near the gut arteries. They would be treated with a branched stent-graft placed through the arteries.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Aortic aneurysm of at least 6 cm (2.4 in) across in men or at least 5.5 cm (2.2 in) in women; or larger than 5 cm (2 in) and growing more than 5 mm/year; or iliac aneurysm larger than 4 cm (1.6 in). Expected to live more than 2 years. Artery shape must allow repair from inside the blood vessel. Surgery risk similar to published rates for standard open surgery.
Main reasons for not taking part
- The aneurysm has burst open (free rupture)
- Pregnancy
- Known allergy to Nitinol, stainless steel, or polyester
- Serious infection of the body or groin
- Blood clotting problem that cannot be corrected
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Aortic aneurysms:; greater than or equal to 6 cm in diameter in men,; greater than or equal to 5.5 cm in diameter in women,; and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,; and/or iliac aneurysms larger than 4 cm in diameter
- Anticipated mortality comparable to published rates with conventional surgical treatment
- Life expectancy more than 2 years
- Ability to give informed consent
- Willingness to comply with follow-up schedule
- Suitable arterial anatomy for endovascular repair
Who cannot take part
- Known allergy to Nitinol, stainless steel, or polyester
- Serious systemic or groin infection
- Free rupture of the aneurysm
- Pregnancy
- Unwillingness or inability to comply with the follow up schedule
- Uncorrectable coagulopathy
Where in United States
- Division of Vascular Surgery, SFVAMCSan Francisco, United StatesContact: Warren J Gasper, MD (principal investigator)Taking people
- Division of Vascular Surgery, UCSFSan Francisco, United StatesContact: Linda M Reilly, MD (sub-investigator)Taking people
About the trial
What the trial wants to find out
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
The group in the trial
- InterventionalTreatment being tested
Endovascular Branched Stent-Graft: The investigational operation is done making small incisions in both groins and the right arm and placing a graft in the aorta through tubes that are inserted through the femoral and brachial arteries, than fastening it in position with metal springs(stents).
Treatment: Endovascular Branched Stent-Graft
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- Plain-language title
- Stent-graft treatment for aortic aneurysms near the abdominal organ arteriesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Multicenter Prospective Evaluation of Patient Radiation Exposure During Fenestrated-branched Endovascular Aortic Repair: A Ten-year Experience.Annals of surgery, 2026
- Trends and outcomes over time with fenestrated and branched endovascular aortic repair in the United States Aortic Research Consortium.Journal of vascular surgery, 2025
- Early and Late Aortic-Related Mortality and Rupture After Fenestrated-Branched Endovascular Aortic Repair of Thoracoabdominal Aortic Aneurysms: A Prospective Multicenter Cohort Study.Circulation, 2024
- Severity of acute kidney injury is associated with decreased survival after fenestrated and branched endovascular aortic aneurysm repair.Journal of vascular surgery, 2023
- Predictors and outcomes of spinal cord injury following complex branched/fenestrated endovascular aortic repair in the US Aortic Research Consortium.Journal of vascular surgery, 2023
- Multibranched endovascular aortic aneurysm repair in patients with and without chronic aortic dissections.Journal of vascular surgery, 2019
- Long-term durability of multibranched endovascular repair of thoracoabdominal and pararenal aortic aneurysms.Journal of vascular surgery, 2019
- Record updated
- 10 November 2026